Maximus GLP-1 Reviews (2026): Real Cost, the FDA Warning, and Who It Fits

Maximus GLP-1 reviews need context: many company reviews cover testosterone care. Maximus is a real telehealth company, but its $99.99-a-month compounded tirzepatide plan requires $1,199.88 up front. That medicine isn't FDA-approved. FDA warned Maximus in June 2026 about its compounded drug claims. It can fit cash payers whose clinician supports compounding, but it doesn't take insurance.

The lowest monthly price isn't the smallest payment. Below, we show what each listed plan costs up front, what the shipping policy says about days of medicine, and the places where Maximus's own pages disagree with each other.

RX Index Decision Verdict: A real, men's-health-first telehealth company with flat pricing for compounded tirzepatide. But its lowest compounded price needs a big prepayment, its own pages disagree on key terms, and its listed brand-name costs run above Ro's while the offers in our comparison apply.

• Best for: Cash-paying adults whose clinician supports a compounded plan, who can prepay, and who want one portal for testosterone and weight care.
• Not ideal for: Anyone who needs insurance, Medicare, or Medicaid; the lowest brand-name price; money back after medicine ships; or care in Alabama, Louisiana, or Mississippi.
• The factor that matters most: The medicine, the amount charged today, and the renewal date on your checkout screen.

Already a member and want to cancel or pause? Jump to cancel and refund help.

What Maximus sells for weight loss, and what it costs

Maximus sells two kinds of GLP-1 care. Compounded tirzepatide and semaglutide are mixed by a pharmacy and are not FDA-approved. Brand-name Zepbound, Wegovy, and Foundayo are FDA-approved and have separate prices by product and dose.

A few words first. GLP-1 medicines (like Zepbound and Wegovy) help control appetite and blood sugar. Compounded means a pharmacy made the medicine itself; FDA does not check compounded drugs for safety, effectiveness, or quality before they're sold (FDA). Off-label means a doctor prescribes an FDA-approved drug for a use that isn't on its FDA label.

Maximus GLP-1 programs, as listed on October 20, 2026

Sources: Maximus weight-loss page, tirzepatide page, microdose page, and Help Center weight-loss pricing and brand-name pricing (both dated June 3, 2026). Brand prices can go up with dose; the Maximus vs. Ro table below breaks out Zepbound, Wegovy, and Foundayo. FDA labels confirm the approved Foundayo tablets, Wegovy tablets and injections, and Zepbound. Ozempic and Mounjaro are approved drugs whose labels do not include weight loss.

Two things trip people up here:

• There are two different $99.99 prices. One is the 12-month compounded tirzepatide plan, paid up front. The other is the advertised monthly price for microdose semaglutide. They're different products.
• Many Maximus reviews are about testosterone care, not GLP-1s. Before you trust a review, check which program the person used.

The microdose plan is not a weight-loss plan. Maximus says so in plain words: "This is not a weight-loss protocol." Maximus markets it for metabolic health, but these compounded products are not FDA-approved. There's no BMI or weight bar; a physician checks for certain health conditions after you enroll. Maximus says you get a full refund if you're found not eligible, and a clinician checks in at day 45 (Maximus microdose page). To compare it with other programs, see our microdosing guide.

For more on the pills, see our Foundayo review and Wegovy pill review.

The $99.99 catch: what the compounded tirzepatide plan charges today

On October 20, 2026, Maximus listed compounded tirzepatide at $99.99 to $199.99 a month. Each plan is billed up front for the full term, so the 12-month plan's $99.99 a month is one $1,199.88 charge. Maximus says the price is the same at every dose.

What each plan charges today, and how much medicine it covers

Prices and plan terms: Maximus tirzepatide page, October 20, 2026. Days of medicine: Maximus's shipping article (June 3, 2026), which says each 2-month shipment is a 56-day supply. Up-front costs and the last column are our math from the public prices, not a completed checkout. Labs, if required, are extra. We haven't confirmed whether the June shipping rule applies to every current plan, including the newer 2-month plan.

What else the page says:

• Renewal: "Your plan renews at the same flat rate at the end of the term unless you cancel before the renewal date."
• Shipping: every plan ships every 2 months. Shipping is free. There's no membership fee.
• Split payments: Klarna may let you pay in parts. Paying in installments does not remove the full-term commitment; check the financing terms for any interest or fees. Maximus's refund policy says committed plans can't be ended early for a partial refund, whether you paid in full or in installments (refund policy, July 15, 2026).

Say you're choosing between plans. The 4-month plan is $599.96 today. Buying the 2-month plan twice would be $799.96 for four advertised plan-months—16 weeks if the June shipping rule applies. So the longer plan saves $200. But it also puts $599.96 at risk before you know if the medicine suits you.

Does a "12-month" plan cover a full year?

The public pages don't confirm a full year's supply. Under the June shipping article's rule, each 2-month shipment holds 56 days of medicine. Six shipments is 336 days, which is 29 days short of a 365-day year. We couldn't confirm that the current 12-month plan uses that same day count.

If the June shipping rule applies, $99.99 buys 28 days of medicine, which works out to about $107 for every 30 days. Ask Maximus how many days your current plan covers before you pay.

Where Maximus's own pages disagree

Maximus's sales pages, Help Center, and Terms of Use don't give one answer on price, refunds, states, insurance, or notice of price changes. Some pages may describe older plans that existing members keep; refund terms also differ by program. Get the plan-specific price and refund terms in writing before you pay; save the checkout screen too.

Sources: weight-loss page, tirzepatide page, microdose page, official company information, Terms of Use (updated Sep 30, 2026), and Help Center articles on pricing, plan updates, brand-name pricing, billing, states, and refunds. All checked October 20, 2026.

It's like a menu taped to the window that doesn't match the menu inside. Ask which one applies, and take a picture of it.

Before you pay: get these 8 answers in writing

Copy this list into a message to Maximus support. Save the replies.

1. Which medicine is this, and is it compounded or FDA-approved?
2. How much will you charge my card today?
3. When does my plan renew, and for how much?
4. How many days of medicine come in each shipment?
5. Are labs required for me? What will they cost?
6. If a doctor turns me down, how much do I get back? What is the consultation fee?
7. Which pharmacy will fill my prescription and ship to my state?
8. If I stop early, what happens to the months I've already paid for?

The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and its drug list, whether you want FDA-approved or compounded medicine, a shot or a pill, and your budget. The RX Index's Find My GLP-1 Path tool asks a few quick questions and shows the GLP-1 paths and providers that fit your goals, budget, insurance, and situation. It's free, takes about 2 minutes, and needs no signup.

See which GLP-1 path fits you

Brand-name Zepbound, Wegovy, and Foundayo: Maximus vs. Ro, dose by dose

Maximus combines medicine, clinical care, and shipping in one monthly price for brand-name GLP-1s, with $100 off the first month and no membership fee. Ro charges for the medicine and a membership separately. At the doses we checked, Ro's medicine plus monthly membership cost less while the listed offers applied, often by about $50 to $150.

How each one charges:

• Maximus: the price covers the medicine (filled by The Pharmacy Hub), clinical care, and shipping. Monthly plans only. Labs cost extra if required. No insurance. (Maximus brand-name pricing, June 3, 2026; first-month prices match the sales page on October 20.)
• Ro: membership is $39 the first month (Ro refunds it if you're not eligible), then $149 a month, or $74 a month on the annual plan ($888 paid up front). Medicine costs extra. Ro says its cash prices match LillyDirect, NovoCare, and TrumpRx. (Ro pricing, October 20, 2026.)

Below, "Ro month 1" adds one medication fill to the $39 first membership month. "Ro after" adds one fill to the $149 monthly membership, the closest match to Maximus's monthly plan. These are medicine and program charges, before required Maximus labs, any extra supplies, or applicable taxes. A Zepbound KwikPen fill covers 28 days. This table compares prices, not doses. Your clinician decides your dose.

Same medicine, same dose: listed medicine and program charges on October 20, 2026

Sources: Maximus brand-name price list, Ro pricing, and Lilly's self-pay terms, checked October 20, 2026. We couldn't confirm each provider's extra supply charges, including pen needles.

Some of Ro's lower prices depend on offers. Read these before you decide:

• * Ro's $449 Zepbound price for 7.5 to 15 mg is Lilly's offer. You keep it only if each refill is bought within 45 days of the last delivery. Without it, Lilly lists $499 (7.5 mg) and $699 (10 to 15 mg). At 10 to 15 mg, that makes Ro's total $848 a month, which is $98.01 more than Maximus. Lilly's self-pay card also allows up to 11 fills per calendar year and ends December 31, 2026. It requires an adult U.S. or Puerto Rico resident with a prescription for an FDA-approved use, cash payment, and no claim for insurance reimbursement or deductible credit. Other eligibility rules apply; this is separate from Lilly's commercial-insurance card (Lilly).
• † Ro's $199 Wegovy pen price is for the first two months at 0.25 or 0.5 mg (sign up by December 31, 2026). After that, Ro lists $349, which would make Ro's total $48.01 more than Maximus at those doses.
• ‡ Ro's Foundayo 2.5 mg ($149) and 5.5 mg ($199) prices are limited-time offers (sign up by December 31, 2026). Ro's regular prices are $199 and $299.
• § Ro lists Foundayo 14.5 and 17.2 mg at $299 with a manufacturer offer ("save $150"). Without it, Ro's total would be $98.01 more than Maximus.
• Ro's annual membership lowers the ongoing monthly equivalent by $75, but it's $888 up front after the first membership month.

The short version: Maximus and Ro are close at Foundayo 0.8 mg and the Wegovy pill 4 mg ($1.99 a month apart). Maximus can come out cheaper when one of Ro's offers ends. At every other dose we checked, Ro cost less after the first month while the listed offers applied. Maximus's edge is simplicity: medicine, care, and shipping in one price, no membership, month to month. Required labs cost extra.

If you want FDA-approved medicine and you're paying cash, Ro listed lower prices than Maximus at most doses we checked, for the same brand-name medicines. Keep the membership in mind: $39 the first month, then $74 to $149 a month depending on the plan you pick.

Paid link: See Ro's FDA-approved GLP-1 prices

A six-fill cost example

Say your clinician has you on Zepbound 10 mg and you pay cash. Here's a six-fill comparison using October 20, 2026 prices and six Ro membership charges. It assumes the same dose and unchanged prices throughout. Six fills supply 24 weeks of medicine, but payment dates can differ. This is a math example, not a quote for your next six fills or a dosing plan.

With the offer on all six fills, Ro is $921.94 less in this example. With no discount on any fill, Ro's model uses $738 first, then five charges of $848; Maximus is $578.06 less. That last row does not describe what automatically happens after one late refill. A late refill can change that fill's price; check each fill's eligibility.

Six fills begun now would extend into 2027. Lilly's current self-pay card expires December 31, 2026, so these figures compare today's rates; they don't predict 2027 prices. Required Maximus labs and any extra supplies or taxes are outside this example.

Already have a prescriber? You may not need a telehealth membership at all. See Ro vs. LillyDirect and how the Zepbound savings card works.

Extra costs, insurance, HSA, and FSA

Maximus says its prices cover the medicine and shipping, with no membership fee, and its brand-name prices also list clinical oversight. Labs cost extra when they're required, and Maximus doesn't take insurance. HSA and FSA cards are accepted.

Sources: tirzepatide page, Help Center articles on labs, refills, and shipping (Jun 3, 2026), lab costs (Jul 23, 2026), and pricing (Jun 3, 2026). For costs that hide behind low prices at other companies too, see hidden telehealth fees.

Does Maximus take insurance?

No. Plan on paying cash. Maximus's billing article says, "Insurance is not accepted" (billing, July 14, 2026). One comparison box on the sales page says insurance and savings cards "may apply," but the Help Center says otherwise. If insurance is key to your budget, don't sign up based on that box.

Can you use an HSA or FSA?

An HSA (health savings account) and FSA (flexible spending account) let you pay for eligible health costs with pre-tax money (IRS Publication 969, 2025 edition). Maximus accepts both cards and says it can send documentation if your plan asks. A card going through doesn't establish that an expense qualifies for tax-free payment. IRS rules and any FSA plan requirements still apply. Check with your plan administrator and keep your receipts. More here: are compounded GLP-1s HSA/FSA-eligible?

What Maximus GLP-1 reviews actually say

On October 20, 2026, Trustpilot showed Maximus at 4.4 out of 5 from 1,096 reviews, with 82% five-star and 10% one-star. Many of those reviews are about testosterone care, not weight loss. Reviews tell you about service, not whether a medicine is safe or works.

What happy reviewers mention: quick replies from support, an easy start, and refills that arrive on time.

What individual reviewers mention: These company-wide reviews did not name the treatment. Pam Con gave five stars and praised service but wrote: "I just wish after the initial shipment, the cost was not so high" (experience May 10, 2026; posted July 10). Christopher Perry gave four stars, praised onboarding and his provider, and noted some shipping delays (experience May 5, 2026; posted May 6). Carl Ingersoll said support refunded a 12-month renewal after later blood tests ruled out continuing (July 3, 2026). That refund was one person's resolution, not a promise that other committed plans will be refunded.

Five stars for fast texts don't tell you whether a compounded medicine is right for you. That's a medical question, covered below.

Is Maximus legit? Who's behind it

Yes. Maximus Health, Inc. is a real telehealth company with a Santa Monica, California address on its FDA letter and its Terms. It runs the website and billing. Clinicians from affiliated medical groups prescribe, and partner pharmacies fill and ship.

A 503A pharmacy compounds under rules that generally require a prescription for a specific patient. That is a legal category, not FDA approval of the drug (FDA's compounding rules; Maximus pharmacies).

Terms worth knowing (Terms of Use, updated September 30, 2026):

• Arbitration: the Terms generally require individual arbitration through JAMS in Broward County, Florida, or another agreed location, and include a class-action waiver. They also allow some court claims, including eligible small-claims cases. We didn't find a way to opt out.
• Florida law: the Terms select Florida law and seek to cap liability at what you paid to use the service, subject to rights the law does not let them limit.
• Your data: you agree Maximus can use de-identified health data for research. There's an opt-out.

This review covers Maximus at maximustribe.com, not Maximus, Inc., the government-services company. To spot fake sellers, see how to avoid fake GLP-1s online.

Did the FDA warn Maximus? What the June 2026 letter says

Yes. On June 8, 2026, FDA sent Maximus Health, Inc. a warning letter saying some website claims about its compounded semaglutide and tirzepatide were false or misleading. The letter is about marketing claims, not a finding about drug quality, and it isn't a ban. The warning-letter page we checked on October 20, 2026 did not link a close-out letter.

A warning letter is FDA's formal notice that it thinks a company broke the law. FDA may issue a close-out letter after it verifies that the company has fixed the problems. Think of a warning letter like a referee's yellow card: serious and public, but about how the game was played, not a ruling that the player is out.

What FDA cited, and what we found on Maximus's site on October 20, 2026

Sources: FDA warning letter to Maximus Health, Inc. (MARCS-CMS 730095, dated June 8, 2026, posted June 16, 2026); FDA guidance for telehealth companies; Maximus's tirzepatide page and brand-name overview. We checked the main weight-loss page, tirzepatide, microdose, Foundayo-tablet, and Wegovy-tablet pages, plus the cited Help Center articles; we did not review every page on the site. The older semaglutide URL now redirects to the main weight-loss page.

• FDA asked Maximus to reply in writing within 15 business days. The FDA page doesn't post a reply.
• We track FDA letters in our compounded GLP-1 enforcement tracker.

Is Maximus's tirzepatide FDA-approved? Is compounding still allowed?

No. Maximus's compounded tirzepatide is not FDA-approved, and FDA doesn't review compounded drugs for safety, effectiveness, or quality before they're sold. It's a different product from Zepbound, made by a pharmacy instead of the drugmaker. Maximus's brand-name Zepbound, Wegovy, and Foundayo are FDA-approved products.

When FDA says compounding might make sense. FDA says a compounded drug "might be appropriate if a patient's medical need cannot be met by an FDA-approved drug." A lower price alone does not establish that medical need. FDA has also received reports of dosing mistakes with compounded GLP-1s, some needing hospital care (FDA, current as of October 1, 2026). If your vial or syringe directions are unclear, ask the pharmacist before your first shot.

Is compounding still allowed? Yes, with limits:

• Tirzepatide and semaglutide are off FDA's shortage list, and the extra time FDA gave compounders after the shortages has ended (FDA, current as of April 1, 2026).
• A 503A pharmacy (the kind Maximus says it uses) can compound for a named patient with a prescription. It can't regularly make what FDA calls "essentially copies" of an approved drug, unless a prescriber documents a significant difference for that patient.
• FDA's current rules already say semaglutide and tirzepatide are on neither its shortage list nor its 503B bulks list. That limits when outsourcing facilities can compound from these drug ingredients. In a May 1, 2026 notice, FDA proposed not including semaglutide, tirzepatide, and liraglutide on the 503B bulks list. A June 26 notice extended comments to July 30. We did not locate a final decision in the FDA and Federal Register sources we checked on October 20, 2026.
• Maximus's Terms warn that shortages or regulatory restrictions can affect medication availability.

More: is compounded GLP-1 still available?, compounding rules after the shortage, and compounded vs. brand-name GLP-1s.

About BMI. BMI (body mass index) is a number from your height and weight. Maximus's tirzepatide page says it's best for people with "a BMI of 25 or higher." Zepbound's FDA label is for adults with obesity, or with overweight plus at least one weight-related health problem. In its main trial, that meant a BMI of 30 or more, or 27 to under 30 with a related condition (Zepbound label, revised August 2026). A clinician decides what fits you.

Talk to your own clinician first if this is you

Some health questions come before any provider comparison. If any of these apply, start with your own doctor:

• You're under 18.
• You're pregnant or trying to get pregnant. See GLP-1s, pregnancy, and birth control.
• You have type 1 diabetes.
• You've had an eating disorder. (The microdose plan has no BMI bar, so this matters there too.)
• You or a family member had medullary thyroid cancer, or you have MEN 2 (a rare inherited condition that causes gland tumors). Zepbound's label says not to use it in these cases.
• You've had a serious allergic reaction to tirzepatide or another ingredient in Zepbound. Its label says not to use it in that case.
• You've had pancreatitis (an inflamed pancreas).

Get urgent medical help for severe stomach pain that won't go away. Get emergency care for trouble breathing or swelling of your face or throat. More: GLP-1 hard contraindications and questions to ask your doctor.

Who Maximus fits, and who should look elsewhere

Maximus may fit a cash-paying adult whose clinician supports compounded tirzepatide, who can prepay, and who wants one portal for testosterone and weight care. It's a weaker fit for anyone who needs insurance, the lowest brand-name price, or the option to leave early with money back.

Four quick yes-or-no checks:

1. Are you paying cash, with no insurance for this?
2. Has a clinician told you why a compounded medicine fits you better than an FDA-approved one?
3. Can you pay 2 to 12 months up front, knowing committed plans can't be ended early for a refund?
4. Do you live outside Alabama, Louisiana, and Mississippi?

Four yeses? Maximus may be worth a look; use the 8 questions above before you pay. Any no? The table below points you to a better next step.

Not sure what insurance you have? Look at your card, or call the member number and ask for your plan type and covered-drug list. Not sure of your BMI? Give your honest height and weight at intake; the clinician works it out.

Maximus doesn't take insurance. For eligible people with employer or marketplace coverage, Ro can be a better fit because it helps check coverage and handle prior authorization. Maximus combines medicine, care, and shipping in one price without a separate membership fee. Required labs cost extra.

If you have insurance through work or a marketplace plan, find out whether it covers a GLP-1 before you pay cash anywhere. Ro checks coverage for Ozempic, Wegovy pens, and Zepbound autoinjector pens, and its team handles prior authorization (the paperwork your insurer wants before it pays). Ro says the coverage process usually takes 1 to 3 weeks; that is not a promise of approval (Ro insurance). The membership and medicine are billed separately.

Ro says Medicaid patients are not currently eligible for treatment. Medicare, Medigap, and TRICARE members may qualify for some cash-pay options; that does not mean Ro can bill those plans for treatment. Start with your own plan's rules. Ro also says FEHB members can use its insurance concierge.

Paid link: Check your coverage with Ro

A compounded option with shorter plans

If your clinician supports compounded medicine but you don't want to prepay months ahead, compare another program's full terms. On October 20, 2026, Embody's homepage showed compounded tirzepatide at $119 a month and semaglutide at $69 a month under a sale banner, with plans from 4 to 52 weeks (Embody). We could not verify which plan produces the $119 headline or what the 4-week plan charges up front.

To be fair to Maximus: its $99.99 advertised monthly figure is lower than Embody's $119 headline. These are not matched quotes: Maximus requires $1,199.88 up front, and Embody's homepage does not show which plan produces its headline price. Embody says you can cancel before the next medication shipment, but if that shipment has already been processed, cancellation starts with the following billing cycle. Its pricing varies by the plan length you pick at checkout. On the same day, Embody's Trustpilot score was 3.8 (10,296 reviews), below Maximus's 4.4. Compounded medicine isn't FDA-approved at either company. Our full Embody review has the details.

Want to compare a compounded program that offers a 4-week plan before you prepay? Check the price Embody shows at checkout for the plan length you choose.

Paid link: See Embody's current plans

Maximus vs. Ro vs. Embody at a glance

Sources: Maximus, Ro pricing, Embody, and Trustpilot pages for Maximus, Ro, and Embody, all checked October 20, 2026. For more choices, see the best online tirzepatide providers and the best brand-name GLP-1 providers.

Signing up or already a member: billing, cancel, and refunds

You can turn off renewal in your Maximus dashboard at any time, but that doesn't refund a committed plan. Maximus's policy says multi-month plans run to the end of the term with no partial refund, and shipped medicine can't be returned.

How to cancel or pause

Maximus's official steps are here: Pausing or Canceling Your Maximus Subscription (May 11, 2026). In short:

1. Sign in at app.maximustribe.com.
2. Go to Settings → Manage Subscription and choose Cancel. Maximus says no phone call is needed.
3. Or email support@maximustribe.com. Either way, get a written confirmation and save it with the date.

Pausing: you pick an end date. Your plan restarts on that date unless you extend the pause or cancel. A pause set on the website starts at your next billing cycle, and it doesn't refund the current one.

Skipping your questionnaire doesn't pause billing. Maximus says auto-renewal continues either way. Your billing date and shipping date can also be different (billing, July 14, 2026).

Contact Maximus: support@maximustribe.com · text (888) 270-5641 · chat Monday to Friday, 9 a.m. to 5 p.m. Eastern (official support details).

What you can and can't get back

Source: Return, Refund, & Subscription Policy (July 15, 2026) and the tirzepatide page.

If you're signing up: protect yourself

1. Start at the official site, maximustribe.com.
2. Screenshot checkout: the plan, the amount charged today, the renewal amount, the renewal date, and the days of medicine.
3. Start small if you're unsure. Maximus's refund policy suggests starting month to month. For compounded tirzepatide, the shortest plan shown is 2 months.
4. Set a reminder a week before your renewal date.
5. Check the box when it arrives: your name and medicine on the label, and the storage directions. Report problems within 3 days.
6. Side effects: message your clinician through the portal. Emergencies: call 911.
7. Switching later? Keep your prescription and dose records. A new prescriber may ask for them.

Maximus GLP-1 reviews: frequently asked questions

Is Maximus legit?

Yes. Maximus Health, Inc. is a real telehealth company, and its name and address match FDA's warning letter. FDA sent it a warning letter in June 2026 about website claims for its compounded drugs. That's about marketing, not a ban, but read the terms closely before you pay.

What complaints came up in the Maximus reviews we checked?

In the reviews we read, the cost after the first shipment and some shipping delays came up. Maximus's own billing rules explain other surprises: committed plans can't be ended early for a refund, and skipping your questionnaire doesn't pause billing. Many Maximus reviews are about testosterone care, so check which program a reviewer used.

How much does Maximus GLP-1 cost?

On October 20, 2026, compounded tirzepatide was $99.99 to $199.99 a month, paid up front: $399.98 for 2 months up to $1,199.88 for 12 months. Brand-name Foundayo, Wegovy, and Zepbound started at $199.99 to $449.99 for the first month and rise after that, by dose. Labs cost extra if required.

Is $99.99 what I pay each month?

No. For compounded tirzepatide, $99.99 is the 12-month plan's monthly price, charged as one $1,199.88 payment. The June shipping article uses 28-day supplies for monthly plans and 56-day supplies for its multi-month shipments; confirm the day count for the current plan. Maximus's separate microdose semaglutide plan is also listed at $99.99 a month, but it's a different, low-dose product.

Can I buy one plan without being charged again?

You can turn off auto-renewal in your dashboard (Settings → Manage Subscription) or by emailing support. That stops the next plan renewal. Any payments still owed for the current term remain due. It doesn't refund the plan you already bought, because Maximus doesn't allow early ends or partial refunds on committed plans.

Are labs and doctor visits included?

Maximus charges no membership fee, but labs cost extra when they're required. We couldn't confirm a GLP-1-specific lab price. Ask which tests you need, whether recent outside results qualify, and what new tests will cost. If a doctor turns you down for standard compounded tirzepatide, Maximus keeps a consultation fee it doesn't list on the page we read.

What is the Maximus microdose plan?

It's a low-dose compounded semaglutide ($99.99 a month) or tirzepatide ($132.99 a month) plan for metabolic health. These compounded products are not FDA-approved. Maximus says this is "not a weight-loss protocol." There's no BMI bar, and Maximus says you get a full refund if a physician finds you're not eligible.

Did the FDA warn Maximus?

Yes. FDA's warning letter dated June 8, 2026, cited claims like "Proven to lose weight effectively" and "FDA approved pharmacies" as false or misleading for compounded drugs. We didn't find those exact phrases on the pages we read on October 20, 2026. The FDA warning-letter page we checked that day did not link a close-out letter.

Is Maximus tirzepatide compounded or real Zepbound?

Maximus sells both, at different prices. Its $99.99 to $199.99 tirzepatide is compounded and not FDA-approved. Its Zepbound KwikPen is the FDA-approved brand-name product, starting at $449.99 for the first month.

Is Maximus cheaper than Ro for Zepbound or Wegovy?

At the doses and offers we checked on October 20, 2026, Ro's listed medicine plus monthly membership cost less. The gap was often about $50 to $150 after the first membership month. Required Maximus labs and any extra supplies are outside that comparison. Maximus can come out cheaper at some doses when one of Ro's or Lilly's offers ends.

Does Maximus take insurance, HSA, or FSA?

Maximus doesn't take insurance. It accepts HSA and FSA cards and can send documentation if your plan asks. Whether the expense qualifies for tax-free payment depends on IRS rules and any FSA plan requirements.

Can women use Maximus for weight loss?

Yes. Maximus's weight-loss pages say its program serves men and women. Approval still depends on your state, the medicine, and a clinician's review.

Which states does Maximus serve for GLP-1s?

Maximus's tirzepatide page and state article, updated August 24, 2026, list Alabama, Mississippi, and Louisiana as unavailable. Texas isn't on that list. The state article says microdose tirzepatide may have extra limits depending on the pharmacy. Confirm your specific plan's availability before you pay.

Does a 12-month Maximus plan cover a full year?

The public pages don't confirm that. Under the June shipping article's 56-day rule, six shipments cover 336 days, or 48 weeks. We couldn't verify that the rule applies to the current 12-month plan, so ask Maximus for its day count before you pay.

What we actually verified

Last verified October 20, 2026. What we read: Maximus's weight-loss, tirzepatide, microdose, Foundayo-tablet, and Wegovy-tablet pages (the older semaglutide URL now redirects); Help Center articles on pricing, brand-name medicines, labs, shipping, pharmacies, states, billing, canceling, and refunds; Maximus's Terms of Use (updated September 30, 2026); FDA's warning letter; FDA's pages on compounding and telehealth marketing; the relevant sections of the Zepbound, Wegovy, Foundayo, Ozempic, and Mounjaro labels; Lilly's Zepbound savings terms; Ro's pricing and insurance pages; Embody's homepage; Trustpilot profiles and the three linked customer reviews; the linked Reddit posts; both BBB profiles; the May 1 and June 26 Federal Register notices; and IRS Publication 969. What we did: compared Maximus's pages with each other, did the price math, and compared brand-name prices with Ro dose by dose. What we didn't do: buy anything, submit an intake, or test customer support. Maximus did not review or approve this page.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Our RX Index Score weighs six factors: clinical legitimacy and safety (25%), care and support model (20%), medication options and fit (15%), transparency and honest terms (15%), value / true cost (15%), and access and speed (10%). We haven't scored Maximus, so this page uses our Decision Verdict instead. See how we evaluate providers.

Sources

All checked October 20, 2026. Dates in parentheses are when the source was published or last updated.

Maximus

• Weight-loss page
• Compounded tirzepatide page
• Microdose page
• Former semaglutide URL (redirects to the main weight-loss page as of October 20, 2026)
• Terms of Use (Sep 30, 2026)
• Official information page
• Help Center: Weight Loss Plan Pricing (Jun 3, 2026) · Name-Brand GLP-1 Pricing (Jun 3, 2026) · Name-Brand GLP-1 Medications at Maximus (Jun 3, 2026) · Updates to Your Weight Loss Plan (Jun 3, 2026) · Labs, Refills, and Shipping (Jun 3, 2026) · GLP-1 Availability by State (Aug 24, 2026) · Compounding Pharmacies (May 11, 2026) · Pausing or Canceling (May 11, 2026) · Billing & Subscriptions (Jul 14, 2026) · Return, Refund, & Subscription Policy (Jul 15, 2026) · Lab Testing Costs (Jul 23, 2026)

FDA and labels

• Warning letter to Maximus Health, Inc. (Jun 8, 2026)
• FDA's concerns with unapproved GLP-1 drugs (Oct 1, 2026)
• FDA policies for compounders (Apr 1, 2026)
• FDA guidance for telehealth companies (Jun 15, 2026)
• Federal Register: proposed 503B bulks decision (May 1, 2026)
• Federal Register: comment extension to July 30, 2026 (Jun 26, 2026)
• Foundayo FDA prescribing information (Apr 2026)
• Wegovy tablets and injections FDA prescribing information (2026)
• FDA approval of Wegovy HD 7.2 mg (Mar 19, 2026)
• Zepbound prescribing information (Aug 2026)
• Ozempic prescribing information (May 2026)
• Mounjaro prescribing information (Aug 2026)

Prices and reviews elsewhere

• Lilly: Zepbound savings and self-pay terms
• Ro: weight-loss pricing · Ro: insurance
• Embody homepage
• IRS Publication 969: HSAs and other tax-favored health plans (2025 edition)
• Trustpilot: Maximus · Ro · Embody